rituximab

Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, Daniela Sieghart, Maximilian Koblischke, Peter Mandl, Barbara Kornek, Elisabeth Simader, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Philipp Hofer, Kurt Redlich, Emma Husar-Memmer, Ruth Fritsch-Stork, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H Aberle, Markus Zeitlinger, Leonhard X Heinz, Daniel Aletaha

Annals of the Rheumatic Diseases May 2022, 81 (5) 687-694; DOI: 10.1136/annrheumdis-2021-221558
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases
Jerome Hadjadj, Delphine Planas, Amani Ouedrani, Solene Buffier, Laure Delage, Yann Nguyen, Timothée Bruel, Marie-Claude Stolzenberg, Isabelle Staropoli, Natalia Ermak, Laure Macraigne, Caroline Morbieu, Soledad Henriquez, David Veyer, Hélène Péré, Marion Casadevall, Luc Mouthon, Frederic Rieux-Laucat, Lucienne Chatenoud, Olivier Schwartz, Benjamin Terrier

Annals of the Rheumatic Diseases May 2022, 81 (5) 720-728; DOI: 10.1136/annrheumdis-2021-221508
Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series
Peter Kvacskay, Wolfgang Merkt, Janine Günther, Norbert Blank, Hanns-Martin Lorenz

Annals of the Rheumatic Diseases May 2022, 81 (5) 744-746; DOI: 10.1136/annrheumdis-2021-221756
Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis
Claudius Speer, Maximilian Töllner, Louise Benning, Katrin Klein, Marie Bartenschlager, Christian Nusshag, Florian Kälble, Paula Reichel, Paul Schnitzler, Martin Zeier, Christian Morath, Wilhelm H Schmitt, Raoul Bergner, Ralf Bartenschlager, Matthias Schaier

Annals of the Rheumatic Diseases Apr 2022, 81 (4) 593-595; DOI: 10.1136/annrheumdis-2021-221747
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
Richard A Furie, Gustavo Aroca, Matthew D Cascino, Jay P Garg, Brad H Rovin, Analia Alvarez, Hilda Fragoso-Loyo, Elizabeth Zuta-Santillan, Thomas Schindler, Paul Brunetta, Cary M Looney, Imran Hassan, Ana Malvar

Annals of the Rheumatic Diseases Jan 2022, 81 (1) 100-107; DOI: 10.1136/annrheumdis-2021-220920
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics
Renaud Felten, Pierre-Marie Duret, Elodie Bauer, Nathanael Sedmak, Julien H Djossou, Massiva Bensalem, Marc Ardizzone, Marion Geoffroy, Angelique Fan, Marion Couderc, Jean Hugues Salmon, Laurent Messer, Rose-Marie Javier, Alain Meyer, Emmanuel Chatelus, Christelle Sordet, Luc Pijnenburg, Jérémy Fort, Marina Rinagel, Julia Walther, Cassandre Fabre, Laurent Arnaud, Jean Sibilia, Nicolas Meyer, Francis Berenbaum, isabelle Chary-Valckenaere, Martin Soubrier, Jérémie Sellam, Jacques-Eric Gottenberg

Annals of the Rheumatic Diseases Jan 2022, 81 (1) 143-145; DOI: 10.1136/annrheumdis-2021-220549
B cell depletion impairs vaccination-induced CD8⁺ T cell responses in a type I interferon-dependent manner
Theresa Graalmann, Katharina Borst, Himanshu Manchanda, Lea Vaas, Matthias Bruhn, Lukas Graalmann, Mario Koster, Murielle Verboom, Michael Hallensleben, Carlos Alberto Guzmán, Gerd Sutter, Reinhold E Schmidt, Torsten Witte, Ulrich Kalinke

Annals of the Rheumatic Diseases Dec 2021, 80 (12) 1537-1544; DOI: 10.1136/annrheumdis-2021-220435
Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic disease
Ming-Han Chen, I-Cheng Lee, Ming-Huang Chen, Ming-Chih Hou, Chang-Youh Tsai, Yi-Hsiang Huang

Annals of the Rheumatic Diseases Nov 2021, 80 (11) 1393-1399; DOI: 10.1136/annrheumdis-2021-220774
Response to: ‘Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’’ by Parikh et al
Rona M Smith, Peter A Merkel, David Jayne

Annals of the Rheumatic Diseases Feb 2021, annrheumdis-2020-219329; DOI: 10.1136/annrheumdis-2020-219329
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
Maria Prendecki, Candice Clarke, Helena Edwards, Stacey McIntyre, Paige Mortimer, Sarah Gleeson, Paul Martin, Tina Thomson, Paul Randell, Anand Shah, Aran Singanayagam, Liz Lightstone, Alison Cox, Peter Kelleher, Michelle Willicombe, Stephen P McAdoo

Annals of the Rheumatic Diseases Oct 2021, 80 (10) 1322-1329; DOI: 10.1136/annrheumdis-2021-220626

Main menu

rituximab

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

rituximab

Pages